Nigerian Company Signs Deal To Drive Participation For Foremost Israeli Medical Conference In Tel Aviv

 

A Nigerian company, Fesco Agalu Nigeria Limited has been granted the exclusive right as an agent to drive participation for the forthcoming 19th MIXiii-BIOMED Conference and Exhibition, which holds from 12-14 May, 2020 at David InterContinental in Tel Aviv, Israel.

Fesco Agalu has been mandated by the organisers of the conference to mobilise exhibitors and visitors to the 19th MIXiii-BIOMED Conference and Exhibition not only in Nigeria, but also across West Africa sub region.

The MIXiii-BIOMED is being organised by Israel-based Kenes Exhibition, organiser of the renowned Agritech Israel and the company has been organising over 20 events in Israel, Europe (Italy, Spain), Peru and India.

With the theme “Quality of our extended lives – Pros and Cons”, the 19th MIXiii-BIOMED will expand the scope and range of topics to explore trends and innovations which are shaping the future of the healthcare system to its full extent, discuss prevention, diagnosis, monitoring and treatment domains, emphasizing quality of life extension.

Some of the fields in medicine to be discussed include Targeted Cancer Treatment: Cure?,  Maintenance? – has medicine reached these points?, Decoding the Brain Enigma: Parkinson, Alzheimer’s, ALS, Mental disorders, AI Technology Redefining the future of Biopharma, Care Delivery, and Holistic Medicine, Next Generation BioTherapeutics – Gene Editing, RNAi, Oligos, Cell and Gene Therapies and others, Bright Spots Illuminating the Future of Medical Devices.

Others are Exact and Biological Science Diagnostics – Sensors, Genomics, AI, Imaging, and others, Robotics Role in Future Healthcare Systems, Aging Science and Technology – From single cell to population at large and Bio-convergence – Biologically Inspired Engineering Reshaping Future Medicine.

The MIXiii-BIOMED conferences have successfully hosted over 6,000 industry executives, scientists, doctors, engineers and investors, including approximately 1,000 international participants from over 45 countries and more than 4,500 one-on-one meetings.

Speaking about the agent deal with the Israelis, Execute Director of Fesco Agalu Nigeria Limited, Yahaya Majeed said that the company will use its vast experience in recruiting participants for the 19^th MIXiii-BIOMED holding in May in Tel Aviv. According to him, Fesco Agalu, organiser of Agritech Nigeria, will mobilise stakeholders in the medical field both in the public and private sectors as well as individuals and more importantly Nigerians who are mindful of the impact of modern technology in medicines and health delivery, to be part of the conference which he believes will be of immense values to humanity.

P.M. EXPRESS reports that MIXiii-BIOMED 2020 is co-organized by leading Israeli and international healthcare institutions with the objective of exposing participants to thought leaders and experts and allow local and global attendees to mix and exchange knowledge and ideas.

As the leading event of Israel’s life sciences industry, MIXiii-BIOMED has positioned itself as the main annual meeting place for both Israeli and international players. It presents a unique and exuberating occasion to participate in discussions, panel presentations, product demonstrations and networking opportunities, all paving the way for new business collaborations.